Arsenic intoxication: general aspects and chelating agents

G Bjørklund, P Oliinyk, R Lysiuk, MS Rahaman… - Archives of …, 2020 - Springer
Arsenic (As) is widely used in the modern industry, especially in the production of pesticides,
herbicides, wood preservatives, and semiconductors. The sources of As such as …

Programmed cell death, redox imbalance, and cancer therapeutics

X Dai, D Wang, J Zhang - Apoptosis, 2021 - Springer
Cancer cells are disordered by nature and thus featured by higher internal redox level than
healthy cells. Redox imbalance could trigger programmed cell death if exceeded a certain …

[HTML][HTML] Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy

SK Rout, V Priya, A Setia, AK Mehata, S Mohan… - Biomedicine & …, 2022 - Elsevier
Mitochondria play a crucial part in the cell's ability to adapt to the changing
microenvironments and their dysfunction is associated with an extensive array of illnesses …

Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 positive feedback loop induces cell cycle arrest by dual PI3K/mTOR inhibitor PQR309 in endometrial cancer cell lines

IL Hsin, HP Shen, HY Chang, JL Ko, PH Wang - Cells, 2021 - mdpi.com
Gene mutations in PIK3CA, PIK3R1, KRAS, PTEN, and PPP2R1A commonly detected in
type I endometrial cancer lead to PI3K/Akt/mTOR pathway activation. Bimiralisib (PQR309) …

A recent development of new therapeutic agents and novel drug targets for cancer treatment

ZD Kifle, M Tadele, E Alemu, T Gedamu… - SAGE open …, 2021 - journals.sagepub.com
Despite recent advances in cancer diagnosis, prevention, detection, as well as
management, the disease is expected to be the top cause of death globally. The …

CLEFMA induces intrinsic and extrinsic apoptotic pathways through ERK1/2 and p38 signalling in uterine cervical cancer cells

CY Lee, YH Hsiao, PN Chen, HH Wu… - Journal of Cellular …, 2023 - Wiley Online Library
Although concurrent chemoradiotherapy is the cornerstone of treatment for locally advanced
or recurrent uterine cervical cancer, treatment fails at a high rate. Therefore, the …

Combination treatment with cyclosporin A and arsenic trioxide induce synergistic cell death via non-apoptotic pathway in uterine cervical cancer cells

PJ Wu, IL Hsin, WL Hung, MS Lee, PH Wang… - Chemico-Biological …, 2022 - Elsevier
Cyclosporin A is an immunosuppressive drug with anti-cancer effect. Arsenic trioxide (As 2 O
3), a well-known cancer-inhibiting drug, induced cytotoxicity via apoptosis and autophagy …

Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach

A Mirzaei, F Jahanshahi, F Khatami, LO Reis… - Tissue and Cell, 2022 - Elsevier
Abstract Background Arsenic trioxide (As 2 O 3) as an inorganic compound is used to treat
various cancers and other diseases. It has been reported that arsenic trioxide induced …

Arsenic trioxide induces ferroptosis in neuroblastoma by mediating GPX4 transcriptional inhibition

M Su, X Liu, Y Ma, X Peng, X Xiong… - Clinical and …, 2024 - Wiley Online Library
Neuroblastoma (NB), the most common extracranial solid tumor in childhood, significantly
contributes to cancer‐related mortality, presenting a dearth of efficacious treatment …

Arsenic trioxide preconditioning attenuates hepatic ischemia-reperfusion injury in mice: Role of ERK/AKT and autophagy

C Wang, H Yu, S Lu, S Ke, Y Xu, Z Feng… - Chinese Medical …, 2025 - journals.lww.com
Background: Arsenic trioxide (ATO) is indicated as a broad-spectrum medicine for a variety
of diseases, including cancer and cardiac disease. While the role of ATO in hepatic …